Anika to Participate in the Sidoti Spring Virtual Investor Conference
Get Alerts ANIK Hot Sheet
Join SI Premium – FREE
BEDFORD, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will present at the Sidoti Spring Virtual Investor Conference on Thursday, March 25, 2021 at 8:30 a.m. ET.
A live audio webcast will be available in the Investor Relations section of Anika’s website, www.anika.com. An audio archive of the session will also be available on the website.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe. For more information about Anika, please visit www.anika.com.
For Investor Inquiries:Mark Namaroff Anika Therapeutics, Inc.Executive Director, Investor Relations and Corporate CommunicationsDirect: 781-457-9287[email protected]
Source: Anika Therapeutics Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SRX Global Announces Share Consolidation
- Southern Michigan Bancorp, Inc. Declares Cash Dividend
- Dynacor Group Announces July 2026 Dividend
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Sidoti & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share